H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating on AbSci (ABSI – Research Report) today and set a price target of $7.00.

H.C. Wainwright analyst Heiko Ihle raised the firm’s price target on DRDGold (DRD) to $17.25 from $13.25 and keeps a Buy rating on the shares.

Immunic Inc (IMUX) stock saw a modest uptick, ending the day at $0.95 which represents no change from the prior close of of $0.95. The stock opened at $0.98 and touched a low of $0.92 during the day, ...

HC Wainwright decreased their Q3 2025 EPS estimates for shares of Applied Digital in a research note issued to investors on ...

Charles Allen, CEO of BTCS, stated, " We are thrilled to collaborate with H.C. Wainwright and Freddy to share insights on the ...

Fintel reports that on January 17, 2025, HC Wainwright & Co. downgraded their outlook for CECO Environmental (NasdaqGS:CECO) ...

HC Wainwright restated their buy rating on shares of Vanda Pharmaceuticals (NASDAQ:VNDA – Free Report) in a research report released on Tuesday,Benzinga reports. They currently have a $18.00 price ...

H.C. Wainwright maintained a positive outlook on Axsome Therapeutics (NASDAQ:AXSM), reiterating a Buy stock rating with a ...

Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and ...

Applied DNA Sciences Inc (APDN) stock saw a decline, ending the day at $0.18 which represents a decrease of $-0.01 or -5.26% from the prior close of $0.19. The stock opened at $0.19 and touched a low ...

If you want to stay updated on the latest options trades for SoundHound AI, Benzinga Pro gives you real-time options trades ...

On Friday, H.C. Wainwright reaffirmed its Buy rating and $50.00 price target for Akero Therapeutics (NASDAQ:AKRO), representing significant upside potential from the current trading price of $24.01.